NAIF1
gene geneOn this page
Also known as DKFZp762G199bA379C10.2
Summary
NAIF1 (nuclear apoptosis inducing factor 1, HGNC:25446) is a protein-coding gene on chromosome 9q34.11, encoding Nuclear apoptosis-inducing factor 1 (Q69YI7). Induces apoptosis.
Involved in negative regulation of cell growth and regulation of mitochondrial membrane permeability involved in apoptotic process. Located in cytosol; nucleoplasm; and plasma membrane.
Source: NCBI Gene 203245 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 41 total
- MANE Select transcript:
NM_197956
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25446 |
| Approved symbol | NAIF1 |
| Name | nuclear apoptosis inducing factor 1 |
| Location | 9q34.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZp762G199, bA379C10.2 |
| Ensembl gene | ENSG00000171169 |
| Ensembl biotype | protein_coding |
| OMIM | 610673 |
| Entrez | 203245 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 3 protein_coding_CDS_not_defined, 1 protein_coding
ENST00000373078, ENST00000466139, ENST00000470245, ENST00000488519
RefSeq mRNA: 1 — MANE Select: NM_197956
NM_197956
CCDS: CCDS6889
Canonical transcript exons
ENST00000373078 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001459466 | 128061233 | 128063900 |
| ENSE00001459468 | 128066591 | 128067320 |
Expression profiles
Bgee: expression breadth ubiquitous, 168 present calls, max score 84.33.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.6228 / max 66.4794, expressed in 1561 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 102647 | 3.6228 | 1561 |
Top tissues by expression
251 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| pancreatic ductal cell | CL:0002079 | 84.33 | silver quality |
| granulocyte | CL:0000094 | 83.73 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.61 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 81.41 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 79.78 | gold quality |
| tibialis anterior | UBERON:0001385 | 79.71 | silver quality |
| left testis | UBERON:0004533 | 79.56 | gold quality |
| right testis | UBERON:0004534 | 79.49 | gold quality |
| stromal cell of endometrium | CL:0002255 | 78.59 | gold quality |
| testis | UBERON:0000473 | 78.59 | gold quality |
| leukocyte | CL:0000738 | 78.34 | gold quality |
| right adrenal gland | UBERON:0001233 | 78.32 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 78.24 | gold quality |
| ileal mucosa | UBERON:0000331 | 78.17 | silver quality |
| calcaneal tendon | UBERON:0003701 | 77.94 | gold quality |
| monocyte | CL:0000576 | 77.89 | gold quality |
| left adrenal gland | UBERON:0001234 | 77.87 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 77.84 | gold quality |
| right lobe of liver | UBERON:0001114 | 77.61 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 77.47 | gold quality |
| prefrontal cortex | UBERON:0000451 | 77.39 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 77.30 | gold quality |
| muscle of leg | UBERON:0001383 | 77.28 | gold quality |
| islet of Langerhans | UBERON:0000006 | 77.12 | gold quality |
| gastrocnemius | UBERON:0001388 | 77.03 | gold quality |
| spleen | UBERON:0002106 | 76.64 | gold quality |
| ganglionic eminence | UBERON:0004023 | 76.42 | gold quality |
| ventricular zone | UBERON:0003053 | 76.22 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 75.97 | gold quality |
| skin of abdomen | UBERON:0001416 | 75.93 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-81608 | no | 23.62 |
| E-ANND-3 | no | 3.29 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
76 targeting NAIF1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-12118 | 100.00 | 65.88 | 1270 |
| HSA-MIR-5193 | 100.00 | 67.26 | 1744 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-223-3P | 99.99 | 70.14 | 1140 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-6870-5P | 99.99 | 68.55 | 2115 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-3173-3P | 99.98 | 66.49 | 1217 |
| HSA-MIR-6891-5P | 99.98 | 66.53 | 1372 |
| HSA-MIR-568 | 99.98 | 69.86 | 2084 |
| HSA-MIR-4723-5P | 99.97 | 68.70 | 2034 |
| HSA-MIR-5698 | 99.97 | 68.49 | 2029 |
| HSA-MIR-7111-5P | 99.97 | 68.48 | 2062 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-4753-3P | 99.90 | 71.03 | 3786 |
| HSA-MIR-129-5P | 99.88 | 70.26 | 3273 |
| HSA-MIR-548AZ-5P | 99.83 | 69.94 | 3230 |
| HSA-MIR-548T-5P | 99.83 | 69.91 | 3220 |
| HSA-MIR-5010-3P | 99.83 | 70.60 | 2357 |
| HSA-MIR-6844 | 99.82 | 70.69 | 2423 |
| HSA-MIR-6756-5P | 99.82 | 67.97 | 2466 |
| HSA-MIR-4319 | 99.76 | 69.83 | 2586 |
| HSA-MIR-1179 | 99.71 | 68.70 | 1040 |
| HSA-MIR-3059-5P | 99.70 | 69.93 | 2491 |
| HSA-MIR-6766-5P | 99.68 | 67.70 | 2325 |
| HSA-MIR-24-3P | 99.59 | 69.97 | 1934 |
| HSA-MIR-4649-3P | 99.56 | 66.90 | 1783 |
Literature-anchored findings (GeneRIF, showing 7)
- NAIF1 (C9orf90)is a nuclear protein that induces apoptosis when overexpressed (PMID:16378748)
- The functions of two transposon-derived human proteins: HARBI1, a domesticated transposase-derived protein, and NAIF1, which contains a trihelix motif similar to that described in the Myb-like protein, was investigated. (PMID:18339812)
- NAIF1 is down-regulated in gastric cancer. (PMID:21286669)
- NAIF1 plays a role in regulating cellular migration and invasion through the MAPK pathways and may function as a tumor suppressor in the progression of gastric carcinoma. (PMID:25432142)
- MiR-24 acted as an oncomir, at least partially through regulation of its functional target NAIF1 in non-small cell lung cancer. (PMID:25725584)
- MicroRNA-351 Promotes the Proliferation and Invasion of Glioma Cells through Downregulation of NAIF1. (PMID:32506303)
- Long noncoding RNA SRY-box transcription factor 2 overlapping transcript participates in Parkinson’s disease by regulating the microRNA-942-5p/nuclear apoptosis-inducing factor 1 axis. (PMID:34607512)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | naif1 | ENSDARG00000062753 |
| mus_musculus | Naif1 | ENSMUSG00000039164 |
| rattus_norvegicus | Naif1 | ENSRNOG00000050204 |
| drosophila_melanogaster | CG10209 | FBGN0033971 |
Protein
Protein identifiers
Nuclear apoptosis-inducing factor 1 — Q69YI7 (reviewed: Q69YI7)
All UniProt accessions (1): Q69YI7
UniProt curated annotations — full annotation on UniProt →
Function. Induces apoptosis.
Subunit / interactions. Interacts with HARBI1.
Subcellular location. Nucleus.
Tissue specificity. Widely expressed.
Similarity. Belongs to the NAIF1 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q69YI7-1 | 1 | yes |
| Q69YI7-2 | 2 |
RefSeq proteins (1): NP_931045* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR028002 | Myb_DNA-bind_5 | Domain |
Pfam: PF13873
UniProt features (9 total): region of interest 3, compositionally biased region 3, splice variant 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q69YI7-F1 | 71.92 | 0.43 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 97 (showing top):
GOBP_NEGATIVE_REGULATION_OF_CELL_GROWTH, GOBP_GROWTH, GOBP_MITOCHONDRIAL_TRANSPORT, GOBP_MEMBRANE_ORGANIZATION, GOBP_REGULATION_OF_MEMBRANE_PERMEABILITY, GOBP_CELL_GROWTH, GOBP_REGULATION_OF_GROWTH, MARSON_BOUND_BY_FOXP3_UNSTIMULATED, GOBP_INTRACELLULAR_TRANSPORT, chr9q34, ASH1L_TARGET_GENES, ATF6_TARGET_GENES, CEBPZ_TARGET_GENES, DLX4_TARGET_GENES, GREB1_TARGET_GENES
GO Biological Process (3): negative regulation of cell growth (GO:0030308), regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108), apoptotic process (GO:0006915)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (5): nucleus (GO:0005634), nucleoplasm (GO:0005654), mitochondrion (GO:0005739), cytosol (GO:0005829), plasma membrane (GO:0005886)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular membrane-bounded organelle | 2 |
| cellular anatomical structure | 2 |
| cytoplasm | 2 |
| regulation of cell growth | 1 |
| cell growth | 1 |
| negative regulation of growth | 1 |
| negative regulation of cellular process | 1 |
| apoptotic process | 1 |
| apoptotic mitochondrial changes | 1 |
| regulation of mitochondrial membrane permeability | 1 |
| programmed cell death | 1 |
| apoptotic signaling pathway | 1 |
| execution phase of apoptosis | 1 |
| binding | 1 |
| nuclear lumen | 1 |
| membrane | 1 |
| cell periphery | 1 |
Protein interactions and networks
STRING
1096 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NAIF1 | HARBI1 | Q96MB7 | 801 |
| NAIF1 | KRT36 | O76013 | 612 |
| NAIF1 | POGK | Q9P215 | 537 |
| NAIF1 | SMIM12 | Q96EX1 | 536 |
| NAIF1 | CASP3 | P42574 | 524 |
| NAIF1 | TIGD5 | Q53EQ6 | 511 |
| NAIF1 | ZNF276 | Q8N554 | 508 |
| NAIF1 | TIGD3 | Q6B0B8 | 491 |
| NAIF1 | LRRC40 | Q9H9A6 | 487 |
| NAIF1 | TIGD4 | Q8IY51 | 485 |
| NAIF1 | MNMIP1 | A4FU49 | 485 |
| NAIF1 | SHISA4 | Q96DD7 | 484 |
| NAIF1 | PGBD5 | Q8N414 | 476 |
| NAIF1 | KSR2 | Q6VAB6 | 473 |
| NAIF1 | RIT1 | Q92963 | 471 |
| NAIF1 | ZBTB48 | P10074 | 471 |
IntAct
14 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SOX14 | NAIF1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| NAIF1 | SOX14 | psi-mi:“MI:0915”(physical association) | 0.670 |
| HARBI1 | NAIF1 | psi-mi:“MI:0915”(physical association) | 0.590 |
| CCNDBP1 | NAIF1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NAIF1 | CCNDBP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TERF2 | NAIF1 | psi-mi:“MI:0915”(physical association) | 0.510 |
| NAIF1 | TERF2IP | psi-mi:“MI:0915”(physical association) | 0.370 |
| ING5 | CCDC85C | psi-mi:“MI:0914”(association) | 0.350 |
| TERF2 | NAIF1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (16): NAIF1 (Two-hybrid), NAIF1 (Two-hybrid), NAIF1 (Affinity Capture-MS), NAIF1 (Affinity Capture-MS), NAIF1 (Two-hybrid), NAIF1 (Affinity Capture-MS), NAIF1 (Affinity Capture-MS), NAIF1 (Affinity Capture-MS), NAIF1 (Affinity Capture-MS), DDX18 (Cross-Linking-MS (XL-MS)), NAIF1 (Affinity Capture-RNA), NAIF1 (Affinity Capture-MS), NAIF1 (Affinity Capture-MS), NAIF1 (Affinity Capture-MS), NAIF1 (Two-hybrid)
ESM2 similar proteins: A0A1W2PQ72, A4IFD2, A7MBH3, D3ZXW3, O35260, O35750, O57337, P14003, P15257, P20823, P22361, P35428, P39880, P42128, P53564, P53565, P56524, P81069, P83038, P85037, Q01167, Q01664, Q04666, Q0V8G2, Q14469, Q3UCQ1, Q3ZBG4, Q5R902, Q5ZI27, Q69YI7, Q6NSM8, Q6NZM9, Q6PFD7, Q6ZTZ1, Q7TSZ8, Q7ZX03, Q80ZH1, Q8BIL2, Q8TAK5, Q8UW00
Diamond homologs: A7MBH3, Q5ZI27, Q69YI7, Q6PFD7, Q96NA8, Q9BE21, G3V7P1, O15400, O70257, Q2KJB9, Q3ZBT5, Q501L3, Q5R602, Q5RBW6, Q6GLA1, Q86Y82, Q8NCY6, Q91YU3, Q9ER00
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
41 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 38 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
447 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:128063627:T:TA | donor_gain | 1.0000 |
| 9:128063901:C:CC | acceptor_gain | 1.0000 |
| 9:128063901:C:T | acceptor_loss | 1.0000 |
| 9:128063904:C:CT | acceptor_gain | 1.0000 |
| 9:128066589:A:AC | donor_gain | 1.0000 |
| 9:128066590:C:CC | donor_gain | 1.0000 |
| 9:128066590:CT:C | donor_gain | 1.0000 |
| 9:128063896:GGGGA:G | acceptor_gain | 0.9900 |
| 9:128063897:GGGA:G | acceptor_gain | 0.9900 |
| 9:128063898:GGA:G | acceptor_gain | 0.9900 |
| 9:128063899:GA:G | acceptor_gain | 0.9900 |
| 9:128063906:C:CT | acceptor_gain | 0.9900 |
| 9:128063907:A:T | acceptor_gain | 0.9900 |
| 9:128063908:G:C | acceptor_gain | 0.9900 |
| 9:128063908:G:GC | acceptor_gain | 0.9900 |
| 9:128066584:CACT:C | donor_loss | 0.9900 |
| 9:128066587:TCACT:T | donor_loss | 0.9900 |
| 9:128066588:CAC:C | donor_loss | 0.9900 |
| 9:128066589:ACT:A | donor_gain | 0.9900 |
| 9:128066589:ACTCT:A | donor_loss | 0.9900 |
| 9:128066590:C:CT | donor_loss | 0.9900 |
| 9:128066590:CTC:C | donor_gain | 0.9900 |
| 9:128066590:CTCT:C | donor_gain | 0.9900 |
| 9:128066590:CTCTG:C | donor_gain | 0.9900 |
| 9:128063898:GGACT:G | acceptor_gain | 0.9800 |
| 9:128063899:GACTG:G | acceptor_gain | 0.9800 |
| 9:128063900:ACTG:A | acceptor_gain | 0.9800 |
| 9:128063901:C:A | acceptor_gain | 0.9800 |
| 9:128063902:T:A | acceptor_gain | 0.9800 |
| 9:128066583:TCAC:T | donor_loss | 0.9800 |
AlphaMissense
2112 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:128063726:A:G | L229P | 1.000 |
| 9:128066698:A:G | L135P | 1.000 |
| 9:128066874:C:A | K76N | 1.000 |
| 9:128066874:C:G | K76N | 1.000 |
| 9:128066876:T:C | K76E | 1.000 |
| 9:128066878:A:G | L75P | 1.000 |
| 9:128066881:T:A | D74V | 1.000 |
| 9:128066881:T:C | D74G | 1.000 |
| 9:128066881:T:G | D74A | 1.000 |
| 9:128066882:C:G | D74H | 1.000 |
| 9:128066886:C:A | W72C | 1.000 |
| 9:128066886:C:G | W72C | 1.000 |
| 9:128066887:C:G | W72S | 1.000 |
| 9:128066888:A:G | W72R | 1.000 |
| 9:128066888:A:T | W72R | 1.000 |
| 9:128066889:C:A | K71N | 1.000 |
| 9:128066889:C:G | K71N | 1.000 |
| 9:128066891:T:C | K71E | 1.000 |
| 9:128066892:C:A | K70N | 1.000 |
| 9:128066892:C:G | K70N | 1.000 |
| 9:128066895:C:A | K69N | 1.000 |
| 9:128066895:C:G | K69N | 1.000 |
| 9:128066899:A:T | V68D | 1.000 |
| 9:128066913:T:A | R63S | 1.000 |
| 9:128066913:T:G | R63S | 1.000 |
| 9:128066914:C:A | R63I | 1.000 |
| 9:128066914:C:G | R63T | 1.000 |
| 9:128066934:G:C | N56K | 1.000 |
| 9:128066934:G:T | N56K | 1.000 |
| 9:128066938:A:T | V55D | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000191648 (9:128068882 C>A), RS1000257794 (9:128063332 G>A), RS1000690611 (9:128064496 T>C,G), RS1001619776 (9:128066120 A>T), RS1001766678 (9:128062929 G>A), RS1002503742 (9:128064149 C>T), RS1002650261 (9:128067355 C>A,T), RS1002693067 (9:128064532 C>T), RS1002828032 (9:128065606 A>C,T), RS1003547347 (9:128069119 C>T), RS1003698187 (9:128063047 G>A), RS1004139493 (9:128066209 T>C), RS1004268382 (9:128061276 C>G,T), RS1004342110 (9:128061012 T>A,C), RS1004519387 (9:128067888 G>A)
Disease associations
OMIM: gene MIM:610673 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005951_65 | Body mass index | 5.000000e-09 |
| GCST005977_23 | Monocyte count | 2.000000e-10 |
| GCST005987_46 | Albumin-globulin ratio | 3.000000e-08 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
| EFO:0005091 | monocyte count |
| EFO:0005128 | albumin:globulin ratio measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
12 total (human), top 12 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Tobacco Smoke Pollution | increases expression | 2 |
| triphenyl phosphate | affects expression | 1 |
| beta-lapachone | increases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| abrine | increases expression | 1 |
| licochalcone B | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Valproic Acid | increases methylation | 1 |
| Cyclosporine | increases expression | 1 |
| Lactic Acid | increases expression | 1 |
| Acrylamide | increases expression | 1 |
Cellosaurus cell lines
3 cell lines: 3 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_SZ85 | HAP1 NAIF1 (-) 1 | Cancer cell line | Male |
| CVCL_SZ86 | HAP1 NAIF1 (-) 2 | Cancer cell line | Male |
| CVCL_SZ87 | HAP1 NAIF1 (-) 3 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.